株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

三次元細胞培養の世界市場:市況・市場規模・展望・動向・予測

3D Cell Culture Market (By Technology: Extracellular Matrices, Bioreactors, Gels, Scaffold Free Platform, and Microchips; By Application; By End-User; By Geography) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024

発行 Variant Market Research LLP 商品コード 537278
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
三次元細胞培養の世界市場:市況・市場規模・展望・動向・予測 3D Cell Culture Market (By Technology: Extracellular Matrices, Bioreactors, Gels, Scaffold Free Platform, and Microchips; By Application; By End-User; By Geography) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024
出版日: 2017年07月22日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の三次元細胞培養の市場を調査し、市場の定義と概要、市場への各種影響因子および市場機会の分析、技術・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 序章

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の方向性・動向・展望・視点
  • 市場シェア分析:企業の競合状況
  • バリューチェーン分析
  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
  • ポーターのファイブフォース分析
  • 影響分析

第4章 市場分析・予測:技術別

  • 概要
  • 細胞外マトリックス
    • 現在の動向・分析
    • 市場規模・予測
  • バイオリアクター
    • 現在の動向・分析
    • 市場規模・予測
  • ゲル
    • 現在の動向・分析
    • 市場規模・予測
  • スキャフォールドフリープラットフォーム
    • 現在の動向・分析
    • 市場規模・予測
  • マイクロチップ
    • 現在の動向・分析
    • 市場規模・予測

第5章 市場分析・予測:用途別

  • 概要
  • 研究
    • 現在の動向・分析
    • 市場規模・予測
  • 創薬
    • 現在の動向・分析
    • 市場規模・予測
  • 組織工学
    • 現在の動向・分析
    • 市場規模・予測
  • 臨床
    • 現在の動向・分析
    • 市場規模・予測
  • 幹細胞生物学
    • 現在の動向・分析
    • 市場規模・予測

第6章 市場分析・予測:エンドユーザー別

  • 概要
  • 研究ラボ・機関
    • 現在の動向・分析
    • 市場規模・予測
  • バイオテクノロジー&バイオ医薬品産業
    • 現在の動向・分析
    • 市場規模・予測
  • 病院・診断センター
    • 現在の動向・分析
    • 市場規模・予測

第7章 市場分析・予測:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • その他の地域
    • 中東
    • 南米
    • アフリカ

第8章 企業プロファイル

目次

Global 3D Cell Culture Market is estimated to reach $4,899 billion by 2024; growing at a CAGR of 23.3% from 2016 to 2024. 3D cell culture is the culture of biological cells in micro-assembles devices, where artificially created three-dimensional environment supports the growth of these cells. The micro-environment parameters of these growing cells can be controlled and monitored to a certain extent. Driven by advancements in the field of cell imaging and analytical systems, cells have been increasingly grown in 3D cell culture and have proved to be useful in many applications. Moreover, they are widely used in tissue engineering and drug discovery, owing to its ability to provide physiologically relevant and accurate data for various in-vivo test. 3D cell culture is widely used in various application such as, disease pathology, tissue morphogenesis and engineering, gene and protein expression, regenerative medicine, and others.

Increase in investment by pharmaceutical and biotechnology companies on 3Dcell culture, and growth in number of patients in need for organ transplantation are the key factors supporting the growth of the global 3D cell culture market. Moreover, ban on animal research and testing is also expected to drive 3D cell culture across various applications. However, high initial investments may restrain the growth of the market. Furthermore, development of 3D cell culture for formulating personalized cosmetics would provide growth opportunities for the market in the near future.

The global 3D cell culture market is categorized into technology, application, and end-user. By technology, the market is segmented into extracellular matrices, bioreactors, gels, Scaffold free platform, and microchips. By application, the market is sub-segmented into research, drug discovery, tissue engineering, clinical applications, and stem cell biology. Furthermore, end-user is segmented into research laboratories & institutes, biotechnology & biopharmaceutical industry, and hospital & diagnostic centers.

By geography, the market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France Italy, and others. Asia-Pacific covers China, Japan, India, South Korea, and others. RoW covers South America, Middle East, and Africa.

Key market players comprise Merck & Co., Inc., 3D Biotek LLC, Lonza Group, Kuraray Co., Ltd., Corning Incorporated, Becton, Dickinson and Company, Advanced Biomatrix, Inc., Thermo Fisher Scientific Inc., VWR International, LLC, and Global Cell Solutions, Inc., among others.

The key takeaways from the report

  • The report will provide a detailed analysis of Global 3D Cell Culture Market with respect to major segments such as technology, application, end-user, and geography
  • The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
  • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
  • An exhaustive regional analysis of Global 3D Cell Culture Market from 2015 to 2024 has been included in the report
  • Profile of the key players in the Global 3D Cell Culture Market will be provided, which include key financials, product & services, new developments, and business strategies

Scope of the Global 3D Cell Culture Market

Technology Segments

  • Extracellular Matrices
  • Bioreactors
  • Gels
  • Scaffold Free Platform
  • Microchips

Application Segments

  • Research
  • Drug Discovery
  • Tissue Engineering
  • Clinical Applications
  • Stem Cell Biology

End-User Segments

  • Research Laboratories & Institutes
  • Biotechnology & Biopharmaceutical Industry
  • Hospital & Diagnostic Centers

Geography Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • South Korea
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

Table of Contents

Chapter 1 Prefix

  • 1.1 Market Scope
  • 1.2 Report Description
  • 1.3 Research Methodology
    • 1.3.1 Primary Research
    • 1.3.2 Secondary Research
    • 1.3.3 In-house Data Modeling

Chapter 2 Executive Summary

Chapter 3 Market Outline

  • 3.1 Market Inclination, Trend, Outlook and Viewpoint
  • 3.2 Market Share Analysis: Company's Competitive Scenario
  • 3.3 Value Chain Analysis
  • 3.4 Market Dynamics
    • 3.4.1 Drivers
      • 3.4.1.1 Impact Analysis
    • 3.4.2 Restraints
      • 3.4.2.1 Impact Analysis
    • 3.4.3 Opportunities
  • 3.5 Porter's five forces analysis
    • 3.5.1 Factors Impact Analysis

Chapter 4 3D Cell Culture Market by Technology: Market Size and Forecast, 2015 - 2024

  • 4.1 Overview
  • 4.2 Extracellular Matrices
    • 4.2.1 Current Trend and Analysis
    • 4.2.2 Market Size and Forecast
  • 4.3 Bioreactors
    • 4.3.1 Current Trend and Analysis
    • 4.3.2 Market Size and Forecast
  • 4.4 Gels
    • 4.4.1 Current Trend and Analysis
    • 4.4.2 Market Size and Forecast
  • 4.5 Scaffold Free Platform
    • 4.5.1 Current Trend and Analysis
    • 4.5.2 Market Size and Forecast
  • 4.6 Microchips
    • 4.6.1 Current Trend and Analysis
    • 4.6.2 Market Size and Forecast

Chapter 5 3D Cell Culture Market by Application: Market Size and Forecast, 2015 - 2024

  • 5.1 Overview
  • 5.2 Research
    • 5.2.1 Current Trend and Analysis
    • 5.2.2 Market Size and Forecast
  • 5.3 Drug Discovery
    • 5.3.1 Current Trend and Analysis
    • 5.3.2 Market Size and Forecast
  • 5.4 Tissue Engineering
    • 5.4.1 Current Trend and Analysis
    • 5.4.2 Market Size and Forecast
  • 5.5 Clinical Application
    • 5.5.1 Current Trend and Analysis
    • 5.5.2 Market Size and Forecast
  • 5.6 Stem Cell Biology
    • 5.6.1 Current Trend and Analysis
    • 5.6.2 Market Size and Forecast

Chapter 6 3D Cell Culture Market by End-User: Market Size and Forecast, 2015 - 2024

  • 6.1 Overview
  • 6.2 Research Laboratories & Institutes
    • 6.2.1 Current Trend and Analysis
    • 6.2.2 Market Size and Forecast
  • 6.3 Biotechnology & Biopharmaceutical Industry
    • 6.3.1 Current Trend and Analysis
    • 6.3.2 Market Size and Forecast
  • 6.4 Hospital & Diagnostics Centers
    • 6.4.1 Current Trend and Analysis
    • 6.4.2 Market Size and Forecast

Chapter 7 3D Cell Culture Market by Geography: Market Size and Forecast, 2015 - 2024

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 Current Trend and Analysis
    • 7.2.2 Market Size and Forecast
    • 7.2.3 US
      • 7.2.3.1 Market Size and Forecast
    • 7.2.4 Canada
      • 7.2.4.1 Market Size and Forecast
    • 7.2.5 Mexico
      • 7.2.5.1 Market Size and Forecast
  • 7.3 Europe
    • 7.3.1 Current Trend and Analysis
    • 7.3.2 Market Size and Forecast
    • 7.3.3 Germany
      • 7.3.3.1 Market Size and Forecast
    • 7.3.4 France
      • 7.3.4.1 Market Size and Forecast
    • 7.3.5 United Kingdom
      • 7.3.5.1 Market Size and Forecast
    • 7.3.6 Italy
      • 7.3.6.1 Market Size and Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Size and Forecast
  • 7.4 Asia-Pacific
    • 7.4.1 Current Trend and Analysis
    • 7.4.2 Market Size and Forecast
    • 7.4.3 China
      • 7.4.3.1 Market Size and Forecast
    • 7.4.4 India
      • 7.4.4.1 Market Size and Forecast
    • 7.4.5 Japan
      • 7.4.5.1 Market Size and Forecast
    • 7.4.6 South Korea
      • 7.4.6.1 Market Size and Forecast
    • 7.4.7 Others
      • 7.4.7.1 Market Size and Forecast
  • 7.5 RoW
    • 7.5.1 Current Trend and Analysis
    • 7.5.2 Market Size and Forecast
    • 7.5.3 Middle East
      • 7.5.3.1 Market Size and Forecast
    • 7.5.4 South America
      • 7.5.4.1 Market Size and Forecast
    • 7.5.5 Africa
      • 7.5.5.1 Market Size and Forecast

Chapter 8 Company Profiles

  • 8.1 Merck & Co., Inc.
  • 8.2 3D Biotek LLC
  • 8.3 Lonza Group
  • 8.4 Kuraray Co., Ltd.
  • 8.5 Corning Incorporated
  • 8.6 Becton, Dickinson and Company
  • 8.7 Advanced Biomatrix, Inc.
  • 8.8 Thermo Fisher Scientific Inc.
  • 8.9 VWR International, LLC
  • 8.10 Global Cell Solutions, Inc.
Back to Top